Chinese
Home
About Livzon
Chairman's Speech
Milestones
Leaders' Caring
Company Honors
Cultural Vision
Contact Us
Media
Livzon News
Employment system
Investor Relations
Company Governance
Announcement
Financial Reports
ESG Report
Shareholder Returns
Stock Information
Sustainable Development
Human Development
Board Diversity Policy
Business Ethics
Supplier
Environment, Occupational Health and Safety (EHS)
Philanthropy
Privacy Policy
Tax policy
ESG Ratings and Honors
Product
Leading Products
Products List
ADR Reporting
R&D
R&D Platforms
Livzon microspheres
Livzon Bio
Livzon Research Institute
R&D Achievements
IP Achievements
Overseas Market
Overseas Business
Specialty Products
Certificates
Contact us
Join Us
Social Recruitment
Campus Recruitment
Compensation and Benefits
Appeal Against
Bidding procurement
Tender Announcement
Supplier Login
Supervision and Reporting
Contact information
Online message
ESG report
Shareholder returns
Stock information
Contacts
VOLUNTARY ANNOUNCEMENT THE NOTICE OF DRUG CLINICAL TRIAL APPROVAL OF YJH-012 INJECTION
File size:
172.0KB
File Type:
pdf
2025-06-24
Overseas Regulatory Announcement
183.1KB
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025
68.4KB
2025-06-03
Final Dividend for the year ended 31 December 2024 (Update)
43.2KB
2025-05-29
POLL RESULTS OF THE ANNUAL GENERAL MEETING FOR THE YEAR 2024,THE 2025 FIRST CLASS MEETING OF A SHAREHOLDERS AND THE 2025 FIRST CLASS MEETING OF H SHAREHOLDERS HELD ON 29 MAY 2025
244.5KB
POSITIONS HELD BY CURRENT DIRECTORS AT THE BOARD AND THE BOARD COMMITTEES
159.7KB
2025-05-22
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE UNDER THE BOARD (ADOPTED ON 22 MAY 2025)
233.2KB
Discloseable Transaction Acquisition of Shareholdings in a Vietnamese Company
214.6KB
Next Day Disclosure Return
91.4KB
2025-05-14
CANCELLATION OF THE REPURCHASED H SHARES
119.4KB
